ArticleGenome medicine2022

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.

Florian A Büttner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.